Jennison Associates LLC Cabaletta Bio, Inc. Transaction History
Jennison Associates LLC
- $155 Billion
- Q2 2024
A detailed history of Jennison Associates LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 5,546,467 shares of CABA stock, worth $27.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,546,467
Previous 3,422,984
62.04%
Holding current value
$27.2 Million
Previous $58.4 Million
28.96%
% of portfolio
0.03%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding CABA
# of Institutions
147Shares Held
50.2MCall Options Held
19.9KPut Options Held
41.5K-
Black Rock Inc. New York, NY4.76MShares$23.4 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$19 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$14.9 Million0.04% of portfolio
-
Alkeon Capital Management LLC New York, NY2.62MShares$12.9 Million0.03% of portfolio
-
Fred Alger Management, LLC New York, NY2.52MShares$12.4 Million0.09% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $142M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...